A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer is a research paper published in Redox Biology (2024). On theSindex it has a DataRank of 0.881. It has been cited 34 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0.348
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 32 citers.
National Institutes of Health
Grant: 1P30CA086862-23
NCI NIH HHS
Grant: P01 CA217797
NCI NIH HHS
Grant: P30 CA086862
NIEHS NIH HHS
Grant: P30 ES005605
FWCI
6.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals